Histamine-releasing Factor(s) in Sera of Uraemic Pruritus Patients in a Possible Mechanism of UVB Therapy

Overview

Journal Arch Dermatol Res

Specialty Dermatology

Date 1993 Jan 1

PMID 7508216

Authors

L E Imazu

T Tachibana

K Danno

M Tanaka

S Imamura

Affiliations

Soon will be listed here.

Abstract

Uraemic pruritus is poorly understood despite the high incidence among chronic renal failure (CRF) patients undergoing haemodialysis. Serum histamine levels have been shown to be elevated in CRF patients with itching, and ultraviolet B (UVB) therapy, even if applied to only part of the body surface, has been reported to be beneficial for the generalized relief of the pruritus. A local mechanism of UVB action is suggested by evidence that UVB radiation is able to suppress histamine release from mast cells. However, detailed systemic mechanism(s) remain obscure. Sera from patients with or without uraemic pruritus were incubated with purified rat peritoneal mast cells and the resulting histamine release was compared. A higher histamine release was obtained with sera from uraemic pruritus patients (44.60 +/- 6.32%, n = 9, P < 0.005) than with sera from patients without itching (19.71 +/- 3.14%, n = 5, P > 0.25) and with normal control sera (23.62 +/- 7.14%, n = 6). This increased histamine release was dose-dependently restored to spontaneous release levels in five of seven patients by pre-exposure of the sera to UVB in vitro. From these results, sera of CRF patients with uraemic pruritus were considered to contain some histamine releasing factor(s) which was depleted or diminished by UVB irradiation, suggesting a possible systemic mechanism of UVB action.

References

Schultz B, Roenigk Jr H . Uremic pruritus treated with ultraviolet light. JAMA. 1980; 243(18):1836-7. DOI: 10.1001/jama.243.18.1836. View

NEIMAN R, BISCHEL M, LUKES R . Uraemia and mast-cell proliferation. Lancet. 1972; 1(7757):959. DOI: 10.1016/s0140-6736(72)91523-1. View

Gilchrest B, Stern R, Steinman T, Brown R, Arndt K, Anderson W . Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol. 1982; 118(3):154-6. View

HAMPERS C, Katz A, Wilson R, MERRILL J . Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med. 1968; 279(13):695-7. DOI: 10.1056/NEJM196809262791307. View

Massry S, Popovtzer M, Coburn J, Makoff D, Maxwell M, Kleeman C . Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med. 1968; 279(13):697-700. DOI: 10.1056/NEJM196809262791308. View

Shaff R, BEAVEN M . Increased sensitivity of the enzymatic isotopic assay of histamine: measurement of histamine in plasma and serum. Anal Biochem. 1979; 94(2):425-30. DOI: 10.1016/0003-2697(79)90385-3. View

Toda K, Danno K, Tachibana T, Horio T . Effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells. II. In vitro PUVA inhibits degranulation of rat peritoneal mast cells induced by compound 48/80. J Invest Dermatol. 1986; 87(1):113-6. DOI: 10.1111/1523-1747.ep12523611. View

Gill D, Fonseca V, Barradas M, Balliod R, Moorhead J, Dandona P . Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol. 1991; 44(3):243-5. PMC: 496948. DOI: 10.1136/jcp.44.3.243. View

Danno K, Toda K, Horio T . Ultraviolet-B radiation suppresses mast cell degranulation induced by compound 48/80. J Invest Dermatol. 1986; 87(6):775-8. DOI: 10.1111/1523-1747.ep12458843. View

10.

Yatzidis H, Digenis P, Tountas C . Heparin treatment of uremic itching. JAMA. 1972; 222(9):1183. View

11.

Tapia L, Cheigh J, DAVID D, Sullivan J, Saal S, Reidenberg M . Pruritus in dialysis patients treated with parenteral lidocaine. N Engl J Med. 1977; 296(5):261-2. DOI: 10.1056/NEJM197702032960508. View

12.

Francos G, Kauh Y, Gittlen S, Schulman E, Besarab A, Goyal S . Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus. Int J Dermatol. 1991; 30(12):884-9. DOI: 10.1111/j.1365-4362.1991.tb04360.x. View

13.

Campese V . Autonomic nervous system dysfunction in uraemia. Nephrol Dial Transplant. 1990; 5 Suppl 1:98-101. DOI: 10.1093/ndt/5.suppl_1.98. View

14.

Danno K, Toda K, Horio T . The effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells: PUVA suppresses degranulation of mouse skin mast cells induced by compound 48/80 or concanavalin A. J Invest Dermatol. 1985; 85(2):110-4. DOI: 10.1111/1523-1747.ep12276497. View

15.

Stockenhuber F, Kurz R, Sertl K, Grimm G, Balcke P . Increased plasma histamine levels in uraemic pruritus. Clin Sci (Lond). 1990; 79(5):477-82. DOI: 10.1042/cs0790477. View

16.

YOUNG Jr A, SWEENEY E, DAVID D, Cheigh J, Hochgelerenl E, Sakai S . Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med. 1973; 73(22):2670-4. View

17.

Matsumoto M, Ichimaru K, Horie A . Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol. 1985; 23(6):285-8. View

18.

Gilchrest B, Rowe J, Brown R, Steinman T, Arndt K . Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med. 1977; 297(3):136-8. DOI: 10.1056/NEJM197707212970304. View

19.

Danno K, Fujii K, Tachibana T, Toda K, Horio T . Suppressed histamine release from rat peritoneal mast cells by ultraviolet B irradiation: decreased diacylglycerol formation as a possible mechanism. J Invest Dermatol. 1988; 90(6):806-9. DOI: 10.1111/1523-1747.ep12462027. View

20.

Gilchrest B, Rowe J, Brown R, Steinman T, Arndt K . Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med. 1979; 91(1):17-21. DOI: 10.7326/0003-4819-91-1-17. View